Phase II study of sunitinib (SU) in Japanese patients with unresectable or metastatic, well-differentiated pancreatic neuroendocrine tumor (NET).
Takuji Okusaka
No relevant relationships to disclose
Tetsuhide Ito
No relevant relationships to disclose
Toshirou Nishida
No relevant relationships to disclose
Hisato Igarashi
No relevant relationships to disclose
Nobumasa Mizuno
No relevant relationships to disclose
Kazuo Hara
No relevant relationships to disclose
Chigusa Morizane
No relevant relationships to disclose
Shunsuke Kondo
No relevant relationships to disclose
Satoshi Hashigaki
Employment or Leadership Position - Pfizer
Stock Ownership - Pfizer
Nobuyuki Kimura
Employment or Leadership Position - Pfizer
Stock Ownership - Pfizer
Kyoko Okano
Employment or Leadership Position - Pfizer
Stock Ownership - Pfizer
Junichi Tanuma
Employment or Leadership Position - Pfizer
Stock Ownership - Pfizer
Mami Murakami
Employment or Leadership Position - Pfizer
Stock Ownership - Pfizer
Akira Sawaki
No relevant relationships to disclose
Kenji Yamao
No relevant relationships to disclose
Masayuki Imamura
No relevant relationships to disclose